Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Innospec (IOSP) Shares Outstanding (Weighted Average) (2017 - 2022)

Historic Shares Outstanding (Weighted Average) for Innospec (IOSP) over the last 12 years, with Q4 2022 value amounting to $24.8 million.

  • Innospec's Shares Outstanding (Weighted Average) rose 56.8% to $24.8 million in Q4 2022 from the same period last year, while for Dec 2022 it was $24.8 million, marking a year-over-year increase of 56.8%. This contributed to the annual value of $24.8 million for FY2022, which is 56.8% up from last year.
  • Latest data reveals that Innospec reported Shares Outstanding (Weighted Average) of $24.8 million as of Q4 2022, which was up 56.8% from $24.8 million recorded in Q3 2022.
  • Innospec's Shares Outstanding (Weighted Average)'s 5-year high stood at $24.8 million during Q2 2022, with a 5-year trough of $24.4 million in Q1 2018.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $24.6 million, with a median of $24.6 million in 2020.
  • As far as peak fluctuations go, Innospec's Shares Outstanding (Weighted Average) skyrocketed by 104.77% in 2018, and later grew by 26.05% in 2021.
  • Innospec's Shares Outstanding (Weighted Average) (Quarter) stood at $24.4 million in 2018, then grew by 0.33% to $24.5 million in 2019, then grew by 0.33% to $24.6 million in 2020, then grew by 0.34% to $24.6 million in 2021, then grew by 0.57% to $24.8 million in 2022.
  • Its Shares Outstanding (Weighted Average) stands at $24.8 million for Q4 2022, versus $24.8 million for Q3 2022 and $24.8 million for Q2 2022.